1177
COM:SINOBIOPHARM
Sino Biopharmaceutical Limited
- Stock
Last Close
3.38
22/11 08:08
Market Cap
51.89B
Beta: -
Volume Today
42.39M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 1.67B - | 2.24B 34.17% | 2.88B 28.75% | 3.35B 16.23% | 4.20B 25.18% | 11.43B 172.39% | 5.58B 51.14% | 5.01B 10.22% | 18.57B 270.49% | 5.78B 68.89% | 2.33B 59.65% | |
depreciation and amortization | 174.99M - | 207.50M 18.58% | 295.85M 42.58% | 353.09M 19.35% | 343.39M 2.75% | 1.18B 242.50% | 1.47B 24.65% | 1.65B 12.88% | 992.56M 40.02% | 1.05B 5.48% | ||
deferred income tax | ||||||||||||
stock based compensation | 29.72M - | 18.12M 39.03% | ||||||||||
change in working capital | -90.08M - | 23.97M 126.61% | -372.92M 1,655.66% | 273.59M 173.36% | 430.68M 57.42% | 243.30M 43.51% | -278.65M 214.53% | 261.33M 193.78% | -339.13M 229.77% | -195.59M 42.33% | ||
accounts receivables | 196.31M - | -198.79M 201.26% | -1.31B 558.10% | -421.65M 67.77% | ||||||||
inventory | -180.01M - | -63.57M 64.68% | -40.63M 36.09% | -43.93M 8.12% | -23.69M 46.08% | -102.16M 331.31% | -449.44M 339.93% | -221.45M 50.73% | -57.48M 74.05% | -391.10M 580.47% | ||
accounts payables | -196.31M - | 198.79M 201.26% | 1.31B 558.10% | 421.65M 67.77% | ||||||||
other working capital | 89.93M - | 87.55M 2.65% | -332.28M 479.55% | 317.52M 195.56% | 454.37M 43.10% | 345.46M 23.97% | 170.79M 50.56% | 482.78M 182.68% | -281.66M 158.34% | 195.51M 169.41% | ||
other non cash items | -522.93M - | -632.10M 20.88% | -888.63M 40.58% | -887.60M 0.12% | -1.24B 39.41% | -7.75B 526.65% | -1.45B 81.34% | -1.60B 10.87% | -13.86B 764.15% | -394.56M 97.15% | -2.35B 495.61% | |
net cash provided by operating activities | 1.23B - | 1.84B 49.36% | 1.92B 4.29% | 3.09B 61.14% | 3.73B 20.76% | 5.09B 36.49% | 5.32B 4.52% | 5.33B 0.01% | 5.37B 0.77% | 6.27B 16.75% | ||
investments in property plant and equipment | -455.34M - | -510.47M 12.11% | -1.12B 119.29% | -935.23M 16.45% | -1.46B 56.13% | -1.69B 15.93% | -1.73B 2.44% | -1.86B 7.22% | -1.89B 1.87% | -1.71B 9.95% | ||
acquisitions net | -101.37M - | -48.11M 52.54% | -145.94M 203.32% | -28.31M 80.60% | -288.40M 918.55% | 1.20B 516.63% | -221.67M 118.45% | -4.20B 1,793.28% | -958.70M 77.16% | -58.52M 93.90% | ||
purchases of investments | -99.91M - | -1.19B 1,094.95% | -2.24B 87.74% | -1.37B 38.97% | -1.41B 3.00% | -2.45B 74.05% | -2.89B 18.05% | -7.16B 147.39% | -4.85B 32.32% | -4.48B 7.50% | ||
sales maturities of investments | 52.34M - | 28.42M 45.71% | 1.15B 3,942.04% | 142.02M 87.63% | 419.08M 195.08% | 2.17B 417.15% | 914.27M 57.81% | 5.12B 460.15% | 903.24M 82.36% | 1.08B 19.46% | ||
other investing activites | 63.45M - | -505.80M 897.18% | 822.87M 262.69% | 134.98M 83.60% | 759.52M 462.70% | 160.03M 78.93% | 111.82M 30.13% | 250.41M 123.93% | 4.28B 1,609.28% | 1.10B 74.36% | ||
net cash used for investing activites | -540.83M - | -2.23B 312.29% | -1.54B 31.15% | -2.05B 33.81% | -1.98B 3.67% | -616.10M 68.87% | -3.82B 520.73% | -7.85B 105.15% | -2.52B 67.93% | -4.07B 61.80% | ||
debt repayment | -45.91M - | -154.23M 235.91% | -663.59M 330.25% | -1.27B 91.40% | -789.67M 37.83% | -93.82M 88.12% | -3.20B 3,306.59% | -1.76B 44.93% | -2.83B 60.61% | -8.70B 207.90% | ||
common stock issued | -796.74M - | 6.82B 956.02% | 5.36B 21.45% | 732.81M 86.32% | ||||||||
common stock repurchased | -604.42M - | -32.05M 94.70% | -195.37M 509.59% | -332.93M 70.41% | -867.61M 160.60% | |||||||
dividends paid | -193.06M - | -256.84M 33.03% | -248.27M 3.34% | -398.21M 60.39% | -449.96M 13.00% | -710.33M 57.86% | -819.69M 15.40% | -1.19B 44.81% | -938.49M 20.94% | -1.27B 35.07% | ||
other financing activites | -179.61M - | 1.09B 705.01% | 168.63M 84.48% | 2.08B 1,134.59% | -106.55M 105.12% | 27.56M 125.87% | 28.34M 2.82% | 18.17M 35.88% | 140.16M 671.36% | 7.65B 5,359.82% | ||
net cash used provided by financing activities | -418.59M - | 675.61M 261.40% | -743.23M 210.01% | 413.63M 155.65% | -1.35B 425.46% | -2.18B 61.77% | 2.80B 228.61% | 2.23B 20.27% | -3.23B 244.42% | -3.19B 1.21% | ||
effect of forex changes on cash | 37.15M - | -63.76M 271.62% | -172.47M 170.49% | -215.68M 25.05% | -217.80M 0.98% | 242.47M 211.33% | 95.05M 60.80% | 280.01M 194.59% | -649.71M 332.03% | 47.32M 107.28% | ||
net change in cash | 309.19M - | 221.35M 28.41% | -532.87M 340.73% | 1.23B 331.64% | 189.61M 84.64% | 2.54B 1,241.17% | 4.40B 72.87% | -7.02M 100.16% | -1.02B 14,504.58% | -944.73M 7.80% | ||
cash at beginning of period | 1.95B - | 2.31B 18.56% | 2.65B 14.75% | 2.27B 14.55% | 3.50B 54.55% | 3.69B 5.41% | 6.24B 68.88% | 10.63B 70.51% | 10.62B 0.07% | 9.60B 9.64% | 8.65B 9.84% | |
cash at end of period | 2.26B - | 2.53B 12.13% | 2.12B 16.32% | 3.50B 65.17% | 3.69B 5.47% | 6.24B 68.88% | 10.63B 70.51% | 10.62B 0.07% | 9.60B 9.64% | 8.65B 9.84% | 8.65B 0% | |
operating cash flow | 1.23B - | 1.84B 49.36% | 1.92B 4.29% | 3.09B 61.14% | 3.73B 20.76% | 5.09B 36.49% | 5.32B 4.52% | 5.33B 0.01% | 5.37B 0.77% | 6.27B 16.75% | ||
capital expenditure | -455.34M - | -510.47M 12.11% | -1.12B 119.29% | -935.23M 16.45% | -1.46B 56.13% | -1.69B 15.93% | -1.73B 2.44% | -1.86B 7.22% | -1.89B 1.87% | -1.71B 9.95% | ||
free cash flow | 776.12M - | 1.33B 71.22% | 798.73M 39.89% | 2.16B 169.88% | 2.27B 5.42% | 3.40B 49.70% | 3.59B 5.56% | 3.47B 3.47% | 3.47B 0.18% | 4.56B 31.31% |
All numbers in (except ratios and percentages)